lanthanum has been researched along with cinacalcet in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cases, A | 1 |
| Cunningham, J | 1 |
| Akizawa, T; Kinugasa, E; Koiwa, F; Ogata, H | 1 |
| Negri, AL | 1 |
| Brancaccio, D; Cozzolino, M; Fallabrino, G; Galassi, A; Gallieni, M; Pasho, S | 1 |
| Malluche, HH; Mawad, H; Monier-Faugere, MC | 1 |
| Alonso, M; Andrés, E; Ballarín, J; Bover, J; Canal, C; Farré, N; Olaya, MT; Quílez, B | 1 |
| Bacchetta, J; Cochat, P; Morel, Y; Nicolino, M; Plotton, I; Ranchin, B; Vial, T | 1 |
| Yokoyama, K | 1 |
| Anstey, CM; Gray, NA; Hollett, PR; Krishnasamy, R; Vardesh, DL | 1 |
| Akizawa, T; Mizobuchi, M; Nakazawa, A | 1 |
| Hamano, T | 1 |
| Adema, AY; de Borst, MH; Ter Wee, PM; Vervloet, MG | 1 |
| Bhargava, R; Brenchley, P; Hann, M; Hurst, H; Hutchison, AJ; Kalra, PA | 1 |
| Choukroun, G; Couchoud, C; Jacquelinet, C; Lambert, O; Mercadal, L; Metzger, M | 1 |
9 review(s) available for lanthanum and cinacalcet
| Article | Year |
|---|---|
CKD-MBD: impact on management of kidney disease.
Topics: Aniline Compounds; Bone Diseases, Metabolic; Calcium Metabolism Disorders; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Naphthalenes; Phenethylamines; Polyamines; Propylamines; Renal Insufficiency, Chronic; Sevelamer; Vitamin D; Vitamin D Deficiency; Vitamins | 2007 |
[K-DOQI guidelines for calcium and phosphorus metabolism in chronic kidney disease: outcomes, compliance and new drugs for treatment].
Topics: Calcium; Cinacalcet; Humans; Kidney Failure, Chronic; Lanthanum; Naphthalenes; Phosphorus; Polyamines; Practice Guidelines as Topic; Sevelamer; Treatment Outcome | 2007 |
Preventive measures and new pharmacological approaches of calcium and phosphate disorders.
Topics: Calcium; Chronic Disease; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Lanthanum; Naphthalenes; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Vitamin D | 2008 |
Effects of treatment of renal osteodystrophy on bone histology.
Topics: Bone and Bones; Bone Remodeling; Calcification, Physiologic; Calcitriol; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Lanthanum; Naphthalenes; Parathyroid Hormone; Phosphates; Polyamines; Sevelamer; Vitamin D | 2008 |
Update on the treatment of chronic kidney disease-mineral and bone disorder.
Topics: Aluminum Compounds; Calcinosis; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet, Protein-Restricted; Dietetics; Humans; Kidney Failure, Chronic; Lanthanum; Naphthalenes; Nephrology; Nutrition Assessment; Nutritive Value; Parathyroidectomy; Patient Care Team; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Sevelamer; Vitamin D | 2009 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Paradigm shift in CKD-MBD guideline].
Topics: Bone Density; Bone Diseases, Metabolic; Chronic Disease; Cinacalcet; Dialysis; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Lanthanum; Naphthalenes; Practice Guidelines as Topic | 2010 |
[Bone and calcium update; diagnosis and therapy of metabolic bone disease update. Advances in treatment of CKD-MBD].
Topics: Bone Diseases, Metabolic; Chronic Disease; Cinacalcet; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Klotho Proteins; Lanthanum; Membrane Proteins; Naphthalenes; Vascular Calcification; Vitamin D | 2011 |
[Kidney and bone update : the 5-year history and future of CKD-MBD. Pharmacoeconomics in the field of CKD-MBD].
Topics: Bone Diseases, Metabolic; Carbamates; Chelating Agents; Chronic Disease; Cinacalcet; Cost-Benefit Analysis; Humans; Kidney Diseases; Lanthanum; Minerals; Naphthalenes; Parathyroidectomy; Polyamines; Sevelamer; Vitamin D | 2012 |
Dietary and pharmacological modification of fibroblast growth factor-23 in chronic kidney disease.
Topics: Calcium; Calcium, Dietary; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Diet; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Lanthanum; Naphthalenes; Phosphorus; Phosphorus, Dietary; Polyamines; Renal Insufficiency, Chronic; Sevelamer | 2014 |
1 trial(s) available for lanthanum and cinacalcet
| Article | Year |
|---|---|
A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis.
Topics: Aged; Cardiovascular Diseases; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Female; Follow-Up Studies; Humans; Hydroxycholecalciferols; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Patient Acceptance of Health Care; Patient Dropouts; Phosphates; Phosphorus, Dietary; Renal Dialysis; Sepsis; Sevelamer | 2019 |
5 other study(ies) available for lanthanum and cinacalcet
| Article | Year |
|---|---|
The latest findings in basic and clinical nephrology science.
Topics: Anemia; Cinacalcet; Clinical Trials as Topic; Humans; Kidney Diseases; Kidney Transplantation; Lanthanum; Naphthalenes; Renal Dialysis | 2005 |
The management of secondary hyperparathyroidism.
Topics: Calcium; Cinacalcet; Diet; Humans; Hyperparathyroidism, Secondary; Lanthanum; Naphthalenes; Phosphates; Vitamin D | 2006 |
Precocious puberty and unlicensed paediatric drugs for severe hyperparathyroidism.
Topics: Child, Preschool; Cinacalcet; Drug Approval; Drug Labeling; Hepatocyte Nuclear Factor 1-beta; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Lanthanum; Male; Mutation; Naphthalenes; Puberty, Precocious; Testosterone; Treatment Outcome | 2009 |
Impact of non-traditional phosphate binders and cinacalcet on haemodialysis patient biochemistry, pill burden and cost.
Topics: Administration, Oral; Aged; Aged, 80 and over; Aluminum Hydroxide; Australia; Calcitriol; Calcium Carbonate; Chelating Agents; Cinacalcet; Drug Costs; Female; Health Care Costs; Hemodialysis Units, Hospital; Humans; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2011 |
Effects of the dialysate calcium concentrations and mineral bone disease treatments on mortality in The French Renal Epidemiology and Information Network (REIN) registry.
Topics: Aged; Blood Vessels; Bone and Bones; Calcinosis; Calcium; Cinacalcet; Female; France; Hemodialysis Solutions; Humans; Lanthanum; Longitudinal Studies; Male; Middle Aged; Proportional Hazards Models; Registries; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Vitamin D | 2020 |